Financials in USD. Standardized financial statements.
A compact view of how StageZero Life Sciences Ltd. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $3.80M | $5.07M | $4.15M | $138,704 | $185,874 | $411,669 | $1.05M | $325,806 | $2.11M | $124,076 |
| Revenue Growth? | -25.1% | +22.1% | +2893.3% | -25.4% | -54.8% | -60.9% | +223.5% | -84.6% | +1602.7% | 0.0% |
| Cost of Revenue? | $4.20M | $3.89M | $3.46M | $1.10M | $1.27M | $1.40M | $1.47M | $0 | $0 | $1.57M |
| Gross Profit? | -$403,747 | $1.18M | $695,555 | -$960,911 | -$1.08M | -$992,706 | -$414,702 | $325,806 | $2.11M | -$1.45M |
| Gross Margin? | -10.6% | +23.2% | +16.8% | -692.8% | -580.7% | -241.1% | -39.3% | +100.0% | +100.0% | -1169.1% |
| Operating Expenses? | $7.34M | $9.31M | $4.43M | $4.18M | $3.29M | $4.17M | $3.85M | $3.18M | $4.21M | $5.25M |
| Operating Income? | -$7.75M | -$7.96M | -$3.74M | -$5.11M | -$4.36M | -$3.90M | -$4.26M | -$6.04M | -$6.61M | -$7.12M |
| EBITDA? | -$10.27M | -$5.69M | -$6.26M | -$2.44M | -$2.66M | -$2.25M | -$4.66M | -$5.99M | -$6.93M | -$5.50M |
| Income Before Tax | -$11.42M | -$7.48M | -$6.86M | -$3.48M | -$3.94M | -$2.95M | -$5.91M | -$6.09M | -$6.61M | -$8.83M |
| Income Tax Expense | $0 | $0 | $0 | $830,486 | $1.14M | $1.69M | $0 | -$71,977 | $5,200.455 | $540,597 |
| Net Income? | -$11.42M | -$7.48M | -$6.86M | -$3.48M | -$3.94M | -$2.95M | -$5.91M | -$6.02M | -$6.61M | -$8.83M |
| EPS? | $-0.11 | $-0.10 | $-0.15 | $-0.16 | $-0.23 | $-0.24 | $-0.72 | $-0.90 | $-1.12 | $-2.07 |
| Diluted EPS? | $-0.11 | $-0.10 | $-0.15 | $-0.16 | $-0.23 | $-0.24 | $-0.72 | $-0.90 | $-1.12 | $-2.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality